Introduction

The DNA is the permanent, heritable, genetic information macromolecule which is transcribed by enzymes into RNA, a short-lasting information carrier. The transcriptome is the full set of all RNA molecules in a cell, a total number of cells or in a living organism.

The first efforts to investigate the complete transcriptome started in the early 1990s, and transcriptomics have made a widespread discipline owing to rapid technological advanced. Quantitative transcriptome analysis market is gaining importance as the drug discovery and development tool and in cancer research. Increasing complex human disease are expected to boost the application of quantitative transcriptome analysis in the future.

Increasing worldwide research and development activities for novel cancer therapeutics is expected to fuel the market growth of quantitative transcriptome analysis market. Higher funding allocations to the drug discovery and increasing use of biosimilars to treat severe diseases are propelling the rapid growth of quantitative transcriptome analysis market.

However, ethical and scientific concern of transcriptome analysis, and insufficient skilled personnel is expected to hamper growth of quantitative transcriptome analysis market in the future.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation

Based on the techniques	RNA sequencing (RNA-Seq) Microarrays Expressed Sequence Tag (EST) Method Serial Analysis of Gene Expression (SAGE) Method
Based on product type	Medical Instruments Consumables Services
Based on an application	Drug Discovery and Development Cancer Research Diagnosis Disease Treatment
Based on disease class	Oncology Neurology Immunology Others
Based on an end user	Biopharmaceutical and Biotechnology Industry Diagnostics Laboratories Cancer Research Laboratories Academic Research

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

Key Players

The key players operating in the global quantitative transcriptome analysis market are: Illumina, Inc., F. Hoffmann-La Roche Ltd., BGI Genomics, Qiagen N.V., Thermo Fisher Scientific Inc., Macrogen, Agilent Technologies, 10x Genomics, Promega Corporation., Bio-Rad Laboratories, Inc., GE Healthcare, Fluidigm Corporation, Merck & Co., Inc., and others.